Guest guest Posted April 29, 2011 Report Share Posted April 29, 2011 Thursday April 28, 2011 FDA Panel Endorses Another HCV Drug SILVER SPRING, Md. -- An FDA panel has unanimously endorsed the investigational drug telaprevir for treatment of hepatitis C, making it the second HCV drug in two days to receive passing marks from the panel. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.